Back to Search Start Over

Osteosynthesis-associated infection of the lower limbs by multidrug-resistant and extensively drug-resistant Gram-negative bacteria: a multicentre cohort study.

Authors :
Giannitsioti E
Salles MJ
Mavrogenis A
Rodriguez-Pardo D
Los-Arcos I
Ribera A
Ariza J
Del Toro MD
Nguyen S
Senneville E
Bonnet E
Chan M
Pasticci MB
Petersdorf S
Benito N
O' Connell N
Blanco García A
Skaliczki G
Tattevin P
Kocak Tufan Z
Pantazis N
Megaloikonomos PD
Papagelopoulos P
Soriano A
Papadopoulos A
The Esgiai Collaborators Study Group
Source :
Journal of bone and joint infection [J Bone Jt Infect] 2022 Dec 21; Vol. 7 (6), pp. 279-288. Date of Electronic Publication: 2022 Dec 21 (Print Publication: 2022).
Publication Year :
2022

Abstract

Purpose : The purpose of this study was the clinical and therapeutic assessment of lower-limb osteosynthesis-associated infection (OAI) by multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative bacteria (GNB), which have been poorly studied to date. Methods : A prospective multicentre observational study was conducted on behalf of ESGIAI (the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group on Implant-Associated Infections). Factors associated with remission of the infection were evaluated by multivariate and Cox regression analysis for a 24-month follow-up period. Results : Patients ( n = 57 ) had a history of trauma (87.7 %), tumour resection (7 %) and other bone lesions (5.3 %). Pathogens included Escherichia coli ( n = 16 ), Pseudomonas aeruginosa ( n = 14 ; XDR 50 %), Klebsiella spp. ( n = 7 ), Enterobacter spp. ( n = 9 ), Acinetobacter spp. ( n = 5 ), Proteus mirabilis ( n = 3 ), Serratia marcescens ( n = 2 ) and Stenotrophomonas maltophilia ( n = 1 ). The prevalence of ESBL (extended-spectrum β -lactamase), fluoroquinolone and carbapenem resistance were 71.9 %, 59.6 % and 17.5 % respectively. Most patients ( n = 37 ; 64.9 %) were treated with a combination including carbapenems ( n = 32 ) and colistin ( n = 11 ) for a mean of 63.3 d. Implant retention with debridement occurred in early OAI (66.7 %), whereas the infected device was removed in late OAI (70.4 %) ( p = 0.008 ). OAI remission was achieved in 29 cases (50.9 %). The type of surgery, antimicrobial resistance and duration of treatment did not significantly influence the outcome. Independent predictors of the failure to eradicate OAI were age > 60  years (hazard ratio, HR, of 3.875; 95 % confidence interval, CI95 %, of 1.540-9.752; p = 0.004 ) and multiple surgeries for OAI (HR of 2.822; CI95 % of 1.144-6.963; p = 0.024 ). Conclusions : Only half of the MDR/XDR GNB OAI cases treated by antimicrobials and surgery had a successful outcome. Advanced age and multiple surgeries hampered the eradication of OAI. Optimal therapeutic options remain a challenge.<br />Competing Interests: At least one of the (co-)authors is a member of the editorial board of . The peer-review process was guided by an independent editor, and the authors also have no other competing interests to declare.<br /> (Copyright: © 2022 Efthymia Giannitsioti et al.)

Details

Language :
English
ISSN :
2206-3552
Volume :
7
Issue :
6
Database :
MEDLINE
Journal :
Journal of bone and joint infection
Publication Type :
Academic Journal
Accession number :
36644590
Full Text :
https://doi.org/10.5194/jbji-7-279-2022